Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2).

INTRODUCTION. Severe acute respiratory syndrome due to novel Coronavirus (SARS-CoV-2) related infection (COVID-19) is characterized by severe ventilation perfusion mismatch leading to refractory hypoxemia. To date, there is no specific treatment available for COVID-19. Nitric oxide is a selective pu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Lei, Chong, Su, Binxiao, Dong, Hailong, Bellavia, Andrea, Fenza, Raffaele Di, Fakhr, Bijan Safaee, Gianni, Stefano, Grassi, Luigi Giuseppe, Kacmarek, Robert, Morais, Caio Cesar Araujo, Pinciroli, Riccardo, Vassena, Emanuele, Berra, Lorenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273302/
https://ncbi.nlm.nih.gov/pubmed/32511534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.03.09.20033530
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados